Apteryx Inc. Awarded a Five-Year Contract with the United States Defense Logistics Agency

Apteryx to Provide Dental Imaging Device and Software Technologies to the United States Army, Navy, Air Force and Marine Corps

VANCOUVER, BC / ACCESSWIRE / December 4, 2019 / Apteryx Imaging Inc. (“Apteryx” or “the Company”) is pleased to announce that its wholly-owned subsidiary, Apteryx Inc., has been awarded a maximum $20,900,000 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for hospital equipment and accessories for the Defense Logistics Agency electronic catalog. The five-year contract, # SPE2DH-20-D-0025, is effective through 11/26/2024. The contract award provides Apteryx the ability to serve as a preferred supplier of dental imaging products, software and services to the United States Army, Navy, Air Force and Marine Corp.

“This award builds upon our existing customer relationships within the Department of Defense,” stated Lamar Roberts, president of Apteryx. “We are excited to grow our military and government partnerships through this latest contract.”

The Defense Logistics Agency serves as the United States’ combat logistics support agency, managing the global supply chain for the Army, Navy, Air Force, Marine Corps, Coast Guard, 10 combatant commands and other federal agencies, in addition to partner and allied nations.

To learn more about dental imaging technologies from Apteryx, please visit www.apteryx.com or call 877-278-3799.

About Apteryx Imaging Inc.

Apteryx Imaging has provided dentists and oral health specialists with advanced diagnostic imaging software and device technologies for over 20 years. Our proprietary technologies include XrayVision, XVWeb and XrayVision DCV imaging software solutions, the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors.

Backed by an experienced leadership team and dedicated to a higher level of service and support, Apteryx Imaging is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSXV under the symbol XRAY, the OTCQB under the symbol APTEF, as well as the Frankfurt Stock Exchange under the symbol XRAY.

Media Contact:

Apteryx Inc.
Chris Koch
Phone: 678-293-9413
Email: chris.koch@apteryx.com

Corporate Contact:

Apteryx Imaging Inc.
David Gane, CEO
Phone: 604-434-4614 ext 227
Email: david.gane@apteryx.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Apteryx Imaging Inc.

View source version on accesswire.com:
https://www.accesswire.com/569066/Apteryx-Inc-Awarded-a-Five-Year-Contract-with-the-United-States-Defense-Logistics-Agency

Staff

Recent Posts

8-Year-Old Piano Prodigy Zeke Walters Strikes a Chord at Sinceri Senior Living Community

VANCOUVER, WA / ACCESSWIRE / March 22, 2024 / At just eight years old, Zeke…

1 hour ago

IRLAB Receives Minutes From End-of-Phase 2 Meeting Confirming Alignment with the FDA on the Phase III Program For Mesdopetam

GOTHENBURG, SWEDEN / ACCESSWIRE / March 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB…

1 hour ago

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

OCALA, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or…

1 hour ago

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…

1 hour ago

Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th

Poster presentation delivers pre-clinical results that demonstrate that its lead development product, Telomir-1, elongates telomere…

1 hour ago